BANKATLANTIC BANCORP INC·4

Jan 6, 3:51 PM ET

COLDREN STEVEN 4

4 · BANKATLANTIC BANCORP INC · Filed Jan 6, 2004

Insider Transaction Report

Form 4
Period: 2004-01-06
Transactions
  • Award

    Options to Buy Class A Common Stock

    2004-01-06+1,5316,531 total
    Exercise: $7.41Exp: 2013-03-31Class A Common (1,531 underlying)
  • Award

    Options to Buy Class A Common Stock

    2004-01-06+4,30018,340 total
    Exercise: $5.09Exp: 2007-05-01Class A Common Stock (4,300 underlying)
  • Award

    Options to Buy Class A Common Stock

    2004-01-06+1,7617,511 total
    Exercise: $4.74Exp: 2009-04-06Class A Common Stock (1,761 underlying)
Footnotes (8)
  • [F1]The exercise price of these previously granted and reported stock options was adjusted from $9.68 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).
  • [F2]Reflects an adjustment in the number of shares issuable under previously granted and reported stock options by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).
  • [F3]Options are currently exercisable.
  • [F4]The exercise price of these previously granted and reported stock options was adjusted from $11.18 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).
  • [F5]The exercise price of these previously granted and reported stock options was adjusted from $3.875 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).
  • [F6]The exercise price of these previously granted and reported stock options was adjusted from $6.1957 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).
  • [F7]The exercise price of these previously granted and reported stock options was adjusted from $12.2283 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).
  • [F8]The exercise price of these previously granted and reported stock options was adjusted from $6.6435 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT